Salix Pharmaceuticals Ltd. has a market cap of $2.9 billion; its shares were traded at around $49 with a P/E ratio of 22.5 and P/S ratio of 8.6.
This is the insider trade history vs. stock price of SLXP. For the complete insider trading history of SLXP, click here.
Directors and Officers Recent Trades:
- Director Alonzo Thomas D bought 690 shares of SLXP stock on 08/11/2011 at the average price of 29.72. Alonzo Thomas D owns at least 79,730 shares after this. The price of the stock has increased by 64.87% since.
- Director Alonzo Thomas D sold 4,700 shares of SLXP stock on 12/06/2011 at the average price of 44.43. Alonzo Thomas D owns at least 90,030 shares after this. The price of the stock has increased by 10.29% since.
- Director John F Chappell sold 1,360 shares of SLXP stock on 09/07/2011 at the average price of 29.55. John F Chappell owns at least 552,244 shares after this. The price of the stock has increased by 65.82% since.
- Director John F Chappell sold 2,000 shares of SLXP stock on 08/31/2011 at the average price of 31.14. John F Chappell owns at least 553,604 shares after this. The price of the stock has increased by 57.35% since.
- Director John F Chappell sold 1,000 shares of SLXP stock on 08/29/2011 at the average price of 29.69. John F Chappell owns at least 555,604 shares after this. The price of the stock has increased by 65.04% since.
For the complete insider trading history of SLXP, click here.







RSS